PubMed:1648430 / 140-352 JSONTXT

Annnotations TAB JSON ListView MergeView

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":212},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":212},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This study describes the inheritance of a defect in pyrimidine catabolism and its association with drug-induced toxicity in a patient receiving 5-fluorouracil (FUra) as adjuvant chemotherapy for breast carcinoma."}

    pubmed-sentences-benchmark

    {"project":"pubmed-sentences-benchmark","denotations":[{"id":"S3","span":{"begin":0,"end":212},"obj":"Sentence"}],"text":"This study describes the inheritance of a defect in pyrimidine catabolism and its association with drug-induced toxicity in a patient receiving 5-fluorouracil (FUra) as adjuvant chemotherapy for breast carcinoma."}

    genia-medco-coref

    {"project":"genia-medco-coref","denotations":[{"id":"C4","span":{"begin":52,"end":73},"obj":"NP"},{"id":"C5","span":{"begin":78,"end":81},"obj":"NP"},{"id":"C6","span":{"begin":144,"end":165},"obj":"NP"}],"relations":[{"id":"R1","pred":"coref-pron","subj":"C5","obj":"C4"}],"text":"This study describes the inheritance of a defect in pyrimidine catabolism and its association with drug-induced toxicity in a patient receiving 5-fluorouracil (FUra) as adjuvant chemotherapy for breast carcinoma."}

    GENIAcorpus

    {"project":"GENIAcorpus","denotations":[{"id":"T4","span":{"begin":52,"end":62},"obj":"nucleotide"},{"id":"T5","span":{"begin":99,"end":120},"obj":"other_name"},{"id":"T6","span":{"begin":144,"end":158},"obj":"nucleotide"},{"id":"T7","span":{"begin":160,"end":164},"obj":"nucleotide"},{"id":"T8","span":{"begin":178,"end":190},"obj":"other_name"},{"id":"T9","span":{"begin":195,"end":211},"obj":"other_name"}],"text":"This study describes the inheritance of a defect in pyrimidine catabolism and its association with drug-induced toxicity in a patient receiving 5-fluorouracil (FUra) as adjuvant chemotherapy for breast carcinoma."}

    PubCasesHPO

    {"project":"PubCasesHPO","denotations":[{"id":"AB1","span":{"begin":195,"end":211},"obj":"HP:0003002"}],"text":"This study describes the inheritance of a defect in pyrimidine catabolism and its association with drug-induced toxicity in a patient receiving 5-fluorouracil (FUra) as adjuvant chemotherapy for breast carcinoma."}

    performance-test

    {"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T3","span":{"begin":195,"end":201},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"This study describes the inheritance of a defect in pyrimidine catabolism and its association with drug-induced toxicity in a patient receiving 5-fluorouracil (FUra) as adjuvant chemotherapy for breast carcinoma."}